Skip to content

The effictiveness of group behavioural activation in the treatment of subthreshold depression in primary care in Hong Kong

The effictiveness of group behavioural activation in the treatment of subthreshold depression in primary care in Hong Kong

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TCS-14004601
Enrollment
Unknown
Registered
2014-05-05
Start date
2014-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subthreshold depression

Interventions

Behavioral Activation:Behavioural activation: The Martell and Colleagues 2010 protocol will be used for the content of group BA intervention due to its established efficacy. The objective of the BA in
Behavioral Activation (to be continued):Specific content of the group BA will include psychoeducation with respect to well-being, setting both short and long term goals, the self-monitoring of activit
Behavioral Activation (to be continued):scheduling daily activities and the identification of avoidance and its impact using the Trigger Response Avoidance Pattern model to allow participants to be mo
Care As Usual:Participants assigned to the CAU will receive their medical care from the doctors who work in the general outpatient clinics. They are not referred to mental health intervention but rece
Care As Usual (to be continued):All participants will be informed that their health care utilization, including their visits and use of medications will be recorded using the electronic patient record

Sponsors

School of Public Health, Prince of Wales Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Aged 18 years or above; 2) Score 5-9 by Patient Health Questionnaire depression scale (PHQ-9).

Exclusion criteria

Exclusion criteria: 1) major depression within the past 6 months; 2) lifetime history of other psychiatric disorders including generalized anxiety disorder, psychosis, schizophrenia and bipolar affective disorder, alcohol or substance abuse, presence of serious suicidal risk and medical illness with a prognosis of less than 6 months to live; 3) patients who are receiving current treatment (taking antidepressants or other psychotropic medications or enrolled in any form of psychological interventions) for any depressive disorders or symptoms.

Design outcomes

Primary

MeasureTime frame
Reduction of self-reported depressive symptoms;

Secondary

MeasureTime frame
Incidence of DSM-IV major depression;Improvement in quality of life;Utilization of health services including visits to primary care doctors;activity change and circumstantial change;patients to rate their impairment in 3 life domains including work, social and family/home management;Anxiety symptoms;Satisfaction with delivered care;Quality-adjusted life years;

Countries

China

Contacts

Public ContactProf. Samuel Yeung Shan WONG
yeungshanwong@cuhk.edu.hk+852 2252 8774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026